Canadian Journal of Infectious Diseases and Medical Microbiology / 2019 / Article / Tab 4 / Research Article
Prevalence, Antimicrobial Susceptibility Pattern of Bacterial Isolates, and Associated Factors of Urinary Tract Infections among HIV‐Positive Patients at Hiwot Fana Specialized University Hospital, Eastern Ethiopia Table 4 Antimicrobial susceptibility pattern of Gram-negative bacterial isolates among HIV-positive patients at Hiwot Fana Specialized University Hospital, Eastern Ethiopia, 2016.
Bacterial isolates, Pattern Antimicrobial susceptibility pattern, (%) AM AML CTX CAZ CRO CIP GN NOR TE COT E. coli 24 S 0 (0) 1 (4.2) 17 (70.8) 0 (0) 2 (8.3) 17 (70.8) 19 (79.2) 20 (83.3) 1 (4.2) 1 (4.2) I 1 (4.2) 1 (4.2) 0 (0) 1 (4.2) 1 (4.2) 2 (8.3) 2 (8.3) 1 (4.2) 2 (8.3) 0 (0) R 23 (95.8) 22 (91.7) 7 (29.2) 23 (95.8) 21 (87.5) 3 (20.5) 3 (12.2) 3 (12.5) 21 (87.2) 23 (95.8) K. pneumoniae 15 S 3 (20) 2 (13.3) 11 (73.3) 4 (26.7) 9 (60) 12 (80) 12 (80) 12 (80) 9 (60) 1 (6.7) I 0 (0) 1 (6.7) 0 (0) 1 (6.7) 2 (13.3) 0 (0) 1 (6.7) 0 (0) 0 (0) 0 (0) R 12 (80) 12 (80) 4 (26.7) 10 (66.7) 4 (26.7) 3 (20) 2 (13.3) 3 (20) 6 (40) 12 (93.3) P. mirabilis 6 S 3 (50) 2 (33.3) 4 (66.7) 6 (100) 6 (100) 5 (83.3) 5 (83.3) 6 (100) 1 (16.7) 2 (33.3) I 1 (16.7) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 R 2 (33.3) 4 (66.7) 2 (33.3) 0 (0) 0 (0) 1 (16.7) 1 (16.7) 0 (0) 5 (83.3) 4 (66.7) P. aeruginosa 4 S 0 (0) 0 (0) — 1 (25) — 3 (75) 0 (0) 1 (25) 0 (0) 0 (0) I 0 (0) 0 (0) — 0 (0) — 0 (0) 0 (0) 0 (0) 0 (00) 0 (0) R 4 (100) 4 (100) — 3 (75) — 1 (25) 4 (100) 3 (75) 4 (100) 4 (100) Total, (%) 49 S 8 (16.2) 5 (10.2) 32 (65.3) 11 (22.4) 17 (34.7) 35 (74.1) 36 (76.5) 37 (75.5) 11 (22.4) 4 (8.2) I 2 (4.1) 2 (4.1) 0 (0) 2 (4.1) 3 (6.1) 2 (4.1) 3 (6.1) 1 (2) 2 (4.1) 0 (0) R 39 (79.6) 42 (85.4) 13 (26.5) 36 (73.5) 25 (51) 12 (24.5) 10 (20.4) 9 (18.7) 36 (73.5) 45 (91.8)
S: sensitive; I: intermediate sensitive; R: resistant; AM: ampicillin; AML: amoxicillin; CTX: cefotaxime; CAZ: ceftazidime; CRO: ceftriaxone; CIP: ciprofloxacin; GN: gentamicin; NOR: norfloxacin; TE: tetracycline; COT: cotrimoxazole.